Literature DB >> 7889356

Critical factors of intracerebral microdialysis as a technique to determine the pharmacokinetics of drugs in rat brain.

E C de Lange1, M Danhof, A G de Boer, D D Breimer.   

Abstract

The purpose of this investigation was to determine the effect of experimental conditions on the concentrations of atenolol and acetaminophen in brain microdialysate, and to investigate the feasibility of performing repeated experiments within individual rats. Following intravenous bolus administration, reproducible concentration-time profiles were obtained in plasma and in brain dialysate. Based on corrections for in vitro recoveries of the intracerebral probe, the estimated ratio of the AUC in brain extracellular fluid (AUCbrain ECF) over the AUC in plasma (AUCplasma) +/- S.E.M. was 3.8 +/- 0.6% (n = 6) for atenolol and 18 +/- 2% (n = 6) for acetaminophen. Upon intracerebroventricular administration, interanimal differences in kinetics of acetaminophen in brain dialysate were observed while the concentrations of atenolol were below the detection limit of the assay. The influence of the use of isotonic versus hypotonic perfusate solutions on AUCbrain ECF values after intravenous bolus administration of both drugs was determined. Repeated experiments with the isotonic perfusate (24, 48 and 78 h post-surgery) resulted in AUCbrain ECF values with the ratio of 100: 98: 76% for acetaminophen and 100: 103: 98% for atenolol. Using a hypotonic perfusion solution the ratio of AUCbrain ECF values was 100: 154: 114% for acetaminophen and 100: 378: 427% for atenolol. A clear effect of the temperature of the hypotonic perfusate (24 vs 38 degrees C) on acetaminophen AUCbrain ECF values was revealed. The ratio of AUCbrain ECF values obtained at 24: 38 degrees C was 192: 100%.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7889356     DOI: 10.1016/0006-8993(94)90276-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  30 in total

Review 1.  Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

Authors:  Elizabeth C M de Lange; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  How minimally invasive is microdialysis sampling? A cautionary note for cytokine collection in human skin and other clinical studies.

Authors:  Julie A Stenken; Martin K Church; Carolyn A Gill; Geraldine F Clough
Journal:  AAPS J       Date:  2009-12-01       Impact factor: 4.009

3.  Drug equilibration across the blood-brain barrier--pharmacokinetic considerations based on the microdialysis method.

Authors:  M Hammarlund-Udenaes; L K Paalzow; E C de Lange
Journal:  Pharm Res       Date:  1997-02       Impact factor: 4.200

Review 4.  Application of microdialysis in pharmacokinetic studies.

Authors:  W F Elmquist; R J Sawchuk
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

Review 5.  A review of flux considerations for in vivo neurochemical measurements.

Authors:  David W Paul; Julie A Stenken
Journal:  Analyst       Date:  2015-06-07       Impact factor: 4.616

Review 6.  Drug transport across the blood-brain barrier.

Authors:  William M Pardridge
Journal:  J Cereb Blood Flow Metab       Date:  2012-08-29       Impact factor: 6.200

7.  Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system.

Authors:  J C Bittencourt; P E Sawchenko
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

8.  Vitamin D receptor activation induces P-glycoprotein and increases brain efflux of quinidine: an intracerebral microdialysis study in conscious rats.

Authors:  Matthew R Durk; Jianghong Fan; Huadong Sun; Yingbo Yang; Henrianna Pang; K Sandy Pang; Inés A M de Lannoy
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

9.  Comparison of serum, cerebrospinal fluid and brain extracellular fluid pharmacokinetics of lamotrigine.

Authors:  M C Walker; X Tong; H Perry; M S Alavijeh; P N Patsalos
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

10.  Atenolol offers better protection than clonidine against cardiac injury in kainic acid-induced status epilepticus.

Authors:  M I Read; J C Harrison; D S Kerr; I A Sammut
Journal:  Br J Pharmacol       Date:  2015-08-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.